An Economic Model to Assess the Cost Impact of Using Xpert Carba-R to Screen Carbapenemase-Producing Enterobacterales in Comparison with Standard of Care, in a National Health Service Setting
Open Access
- 19 April 2025
- journal article
- research article
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 14 (6) , 1265-1276
Abstract
Introduction Carbapenemase-producing Enterobacterales (CPE) are bacteria that produce carbapenemases, enzymes that destroy carbapenem antibiotics and result in carbapenem resistance. Early identification of individuals who have been colonised or infected is important to correctly implement infection prevention and control procedures. Chromogenic media culture is traditionally the most common method of screening for high-risk patients. However, there is a long wait for results, which has substantial cost and operational implications. Xpert Carba-R is a rapid molecular test that provides CPE screening results in 50 min. This study aimed to assess the cost impact of high-risk CPE screening with Xpert Carba-R compared with media culture. Methods An economic model was developed using a probabilistic cost–comparison approach to estimate the costs associated with Xpert Carba-R, from a National Health Service and personal social services perspective. The model cohort was individuals at high risk of CPE colonisation and used an 8.30-day mean time horizon for all patients to cover hospitalisation time, with an extra 5.80 days added for patients that were truly colonised to cover the time they would spend in isolation (14.10-day time horizon overall). Deterministic sensitivity analysis and scenario analysis were used to determine the robustness of the findings. Results The model found that Xpert Carba-R is cost saving compared with media culture, with incremental cost savings of £818.28 per person. Despite greater technology costs, there are cost savings associated with preventing unnecessary isolation. Conclusion The analysis found Xpert Carba-R to be cost saving compared with media culture for CPE screening in high-risk patients. The model did not explore onwards transmission or the opportunity cost of releasing isolation spaces, so the cost savings are likely to be far greater than those demonstrated in this study.Keywords
Funding Information
- Cepheid
This publication has 14 references indexed in Scilit:
- Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling studyAntimicrobial Resistance & Infection Control, 2022
- Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United KingdomThe European Journal of Health Economics, 2021
- Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilitiesJournal of Hospital Infection, 2021
- The daily direct costs of isolating patients identified with highly resistant micro-organisms in a non-outbreak settingJournal of Hospital Infection, 2021
- Epidemiology of carbapenemase-producing Enterobacterales in England, May 2015–March 2019: national enhanced surveillance findings and approachInfection Prevention in Practice, 2020
- Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admissionJournal of Hospital Infection, 2018
- Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic reviewAmerican Journal of Infection Control, 2016
- Carbapenem resistance: overview of the problem and future perspectivesTherapeutic Advances in Infectious Disease, 2015
- Comparative Evaluation of a Prototype Chromogenic Medium (ChromID CARBA) for Detecting Carbapenemase-Producing Enterobacteriaceae in Surveillance Rectal SwabsJournal of Clinical Microbiology, 2012